BindingDB logo
myBDB logout

Patent code US11040968

Compile Data Set for Download or QSAR
Found 17 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504319
PNG
(US11040968, Example 001 | WX001)
Show SMILES Cc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCn12
Show InChI InChI=1S/C24H22FN7O/c1-14-10-17(25)16(11-20(14)31-12-19(26-13-31)15-7-8-15)24(33)28-21-5-2-4-18(27-21)23-30-29-22-6-3-9-32(22)23/h2,4-5,10-13,15H,3,6-9H2,1H3,(H,27,28,33)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.82n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504334
PNG
(US11040968, Example 016 | WX016)
Show SMILES Cc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2C(O)CCCn12
Show InChI InChI=1S/C25H24FN7O2/c1-14-10-17(26)16(11-20(14)32-12-19(27-13-32)15-7-8-15)25(35)29-22-6-2-4-18(28-22)23-30-31-24-21(34)5-3-9-33(23)24/h2,4,6,10-13,15,21,34H,3,5,7-9H2,1H3,(H,28,29,35)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 4.12n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504327
PNG
(US11040968, Example 008 | WX008)
Show SMILES Oc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C24H22FN7O2/c25-16-11-20(33)19(31-12-18(26-13-31)14-7-8-14)10-15(16)24(34)28-21-5-3-4-17(27-21)23-30-29-22-6-1-2-9-32(22)23/h3-5,10-14,33H,1-2,6-9H2,(H,27,28,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 5.44n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504320
PNG
(US11040968, Example 002 | WX002)
Show SMILES Cc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C25H24FN7O/c1-15-11-18(26)17(12-21(15)32-13-20(27-14-32)16-8-9-16)25(34)29-22-6-4-5-19(28-22)24-31-30-23-7-2-3-10-33(23)24/h4-6,11-14,16H,2-3,7-10H2,1H3,(H,28,29,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 5.60n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504336
PNG
(US11040968, Example 018 | WX018)
Show SMILES Cc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2[C@H](O)CCCn12
Show InChI InChI=1S/C25H24FN7O2/c1-14-10-17(26)16(11-20(14)32-12-19(27-13-32)15-7-8-15)25(35)29-22-6-2-4-18(28-22)23-30-31-24-21(34)5-3-9-33(23)24/h2,4,6,10-13,15,21,34H,3,5,7-9H2,1H3,(H,28,29,35)/t21-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 6.57n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504330
PNG
(US11040968, Example 012 | WX012)
Show SMILES FCCOc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C26H25F2N7O2/c27-9-11-37-22-13-18(28)17(12-21(22)34-14-20(29-15-34)16-7-8-16)26(36)31-23-5-3-4-19(30-23)25-33-32-24-6-1-2-10-35(24)25/h3-5,12-16H,1-2,6-11H2,(H,30,31,36)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7.04n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504328
PNG
(US11040968, Example 010 | WX010)
Show SMILES CC1(COc2cc(F)c(cc2-n2cnc(c2)C2CC2)C(=O)Nc2cccc(n2)-c2nnc3CCCCn23)COC1
Show InChI InChI=1S/C29H30FN7O3/c1-29(14-39-15-29)16-40-24-12-20(30)19(11-23(24)36-13-22(31-17-36)18-8-9-18)28(38)33-25-6-4-5-21(32-25)27-35-34-26-7-2-3-10-37(26)27/h4-6,11-13,17-18H,2-3,7-10,14-16H2,1H3,(H,32,33,38)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7.20n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504329
PNG
(US11040968, Example 011 | WX011)
Show SMILES Fc1cc(OCC2COC2)c(cc1C(=O)Nc1cccc(n1)-c1nnc2CCCCn12)-n1cnc(c1)C1CC1
Show InChI InChI=1S/C28H28FN7O3/c29-20-11-24(39-15-17-13-38-14-17)23(35-12-22(30-16-35)18-7-8-18)10-19(20)28(37)32-25-5-3-4-21(31-25)27-34-33-26-6-1-2-9-36(26)27/h3-5,10-12,16-18H,1-2,6-9,13-15H2,(H,31,32,37)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7.61n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504331
PNG
(US11040968, Example 013 | WX013)
Show SMILES FCCCOc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C27H27F2N7O2/c28-10-4-12-38-23-14-19(29)18(13-22(23)35-15-21(30-16-35)17-8-9-17)27(37)32-24-6-3-5-20(31-24)26-34-33-25-7-1-2-11-36(25)26/h3,5-6,13-17H,1-2,4,7-12H2,(H,31,32,37)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7.93n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504333
PNG
(US11040968, Example 015 | WX015)
Show SMILES Fc1cc(N2CCOCC2)c(cc1C(=O)Nc1cccc(n1)-c1nnc2CCCCn12)-n1cnc(c1)C1CC1
Show InChI InChI=1S/C28H29FN8O2/c29-20-15-24(35-10-12-39-13-11-35)23(36-16-22(30-17-36)18-7-8-18)14-19(20)28(38)32-25-5-3-4-21(31-25)27-34-33-26-6-1-2-9-37(26)27/h3-5,14-18H,1-2,6-13H2,(H,31,32,38)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 10.1n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504332
PNG
(US11040968, Example 014 | WX014)
Show SMILES CN(C)c1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C26H27FN8O/c1-33(2)21-13-18(27)17(12-22(21)34-14-20(28-15-34)16-9-10-16)26(36)30-23-7-5-6-19(29-23)25-32-31-24-8-3-4-11-35(24)25/h5-7,12-16H,3-4,8-11H2,1-2H3,(H,29,30,36)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 10.7n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504335
PNG
(US11040968, Example 017 | WX017)
Show SMILES Cc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2[C@@H](O)CCCn12
Show InChI InChI=1S/C25H24FN7O2/c1-14-10-17(26)16(11-20(14)32-12-19(27-13-32)15-7-8-15)25(35)29-22-6-2-4-18(28-22)23-30-31-24-21(34)5-3-9-33(23)24/h2,4,6,10-13,15,21,34H,3,5,7-9H2,1H3,(H,28,29,35)/t21-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 12.5n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504326
PNG
(US11040968, Example 007 | WX007)
Show SMILES COCCOc1cc(F)c(cc1-n1cnc(c1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C27H28FN7O3/c1-37-11-12-38-23-14-19(28)18(13-22(23)34-15-21(29-16-34)17-8-9-17)27(36)31-24-6-4-5-20(30-24)26-33-32-25-7-2-3-10-35(25)26/h4-6,13-17H,2-3,7-12H2,1H3,(H,30,31,36)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 16.6n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504325
PNG
(US11040968, Example 006 | WX006)
Show SMILES Fc1cc(-c2cccnc2)c(cc1C(=O)Nc1cccc(n1)-c1nnc2CCCCn12)-n1cnc(c1)C1CC1
Show InChI InChI=1S/C29H25FN8O/c30-22-13-20(19-5-4-11-31-15-19)25(37-16-24(32-17-37)18-9-10-18)14-21(22)29(39)34-26-7-3-6-23(33-26)28-36-35-27-8-1-2-12-38(27)28/h3-7,11,13-18H,1-2,8-10,12H2,(H,33,34,39)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 19.2n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504324
PNG
(US11040968, Example 005 | WX005)
Show SMILES Cc1cc(F)c(cc1-n1cnc(n1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C24H23FN8O/c1-14-11-17(25)16(12-19(14)33-13-26-22(31-33)15-8-9-15)24(34)28-20-6-4-5-18(27-20)23-30-29-21-7-2-3-10-32(21)23/h4-6,11-13,15H,2-3,7-10H2,1H3,(H,27,28,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 35.3n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504321
PNG
(US11040968, Example 003 | WX003)
Show SMILES Cc1cc(F)c(cc1-n1cc(nn1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C24H23FN8O/c1-14-11-17(25)16(12-20(14)33-13-19(28-31-33)15-8-9-15)24(34)27-21-6-4-5-18(26-21)23-30-29-22-7-2-3-10-32(22)23/h4-6,11-13,15H,2-3,7-10H2,1H3,(H,26,27,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 943n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase kinase kinase 5


(Homo sapiens (Human))
BDBM504322
PNG
(US11040968, Example 004 | WX004)
Show SMILES Cc1cc(F)c(cc1-n1nnc(n1)C1CC1)C(=O)Nc1cccc(n1)-c1nnc2CCCCn12
Show InChI InChI=1S/C23H22FN9O/c1-13-11-16(24)15(12-18(13)33-30-21(28-31-33)14-8-9-14)23(34)26-19-6-4-5-17(25-19)22-29-27-20-7-2-3-10-32(20)22/h4-6,11-12,14H,2-3,7-10H2,1H3,(H,25,26,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a>1.00E+3n/an/an/an/an/an/a



TBA

US Patent


Assay Description
Primary reaction buffer solution: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOTreatme...


US Patent US11040968 (2021)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%